LCTX - Lineage Cell Therapeutics GAAP EPS of -$0.04 in-line revenue of $1.25M misses by $1.33M
2023-11-09 16:05:08 ET
More on Lineage Cell Therapeutics
- A Second Look At Lineage Cell Therapeutics
- Lineage Cell Therapeutics Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Lineage Cell Therapeutics
- Historical earnings data for Lineage Cell Therapeutics
- Financial information for Lineage Cell Therapeutics
For further details see:
Lineage Cell Therapeutics GAAP EPS of -$0.04 in-line, revenue of $1.25M misses by $1.33M